[CLDX] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
03-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY- -37.93%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 6,786 5,480 3,586 4,111 11,202 9,265 46,793 -27.49%
PBT -128,530 -127,197 -118,080 -81,550 -59,123 -44,799 -2,533 92.29%
Tax -8,772 -2,344 -4,350 -819 -530 -446 -5,309 8.72%
NP -128,530 -127,197 -118,080 -81,550 -59,123 -44,799 -2,533 92.29%
Tax Rate - - - - - - - -
Total Cost 135,316 132,677 121,666 85,661 70,325 54,064 49,326 18.29%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -1,894.05 -2,321.11 -3,292.81 -1,983.70 -527.79 -483.53 -5.41 165.24%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -18.99 -19.66 -19.81 -15.33 -15.37 -17.01 -1.19 58.60%
EPS Diluted -18.99 -19.66 -19.81 -15.33 -15.37 -17.01 -1.19 58.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.